Literature DB >> 26829559

Corticosteroid-binding globulin (CBG) reactive centre loop antibodies and surface plasmon resonance interrogate the proposed heat dependent "flip-flop" mechanism of human CBG.

John G Lewis1, Rayleen Fredericks2, Conan J Fee2, Peter A Elder3.   

Abstract

Corticosteroid-binding globulin (CBG) is the predominant carrier of cortisol in circulation and is a non-inhibitory member of the serpin superfamily of serine protease inhibitors. In the stressed or "S" conformation, CBG possesses an intact exposed reactive centre loop (RCL) that can be irreversibly cleaved by elastase released from activated human neutrophils whereupon it adopts a relaxed or "R" conformation. The latter conformation has decreased affinity for cortisol, allowing the release of the majority of cortisol at sites of inflammation. Recently there has been speculation that mild increments in heat such as found in pyrexia (39-40°C) may also induce a reversible "flip-flop" of the RCL into the body of the protein structure, without cleavage, facilitating a reversible temperature-dependent release of cortisol. Here we raised a new monoclonal antibody to the RCL of human CBG and used this in concert with an existing RCL antibody and show by surface plasma resonance that, at temperatures up to 40°C, the RCL of purified CBG and the RCL of CBG in intact plasma is accessible to these two antibodies. Together, the epitopes of these antibodies span 11 consecutive amino acids (STGVTLNLTSK) of the 18 residues of the RCL. This adequate antibody cover of the RCL sequence leads to the conclusion that the proposed temperature-dependent "flip-flop" of the RCL of CBG is doubtful.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  CBG; Corticosteroid-binding globulin; Cortisol; Elastase; Reactive centre loop; Serpins; Temperature

Mesh:

Substances:

Year:  2016        PMID: 26829559     DOI: 10.1016/j.jsbmb.2016.01.013

Source DB:  PubMed          Journal:  J Steroid Biochem Mol Biol        ISSN: 0960-0760            Impact factor:   4.292


  2 in total

1.  Two Monoclonal Antibodies That Specifically Recognize Aspergillus Cell Wall Antigens and Can Detect Circulating Antigens in Infected Mice.

Authors:  Xihua Lian; Stephen Chambers; John G Lewis; Amy Scott-Thomas; Madhav Bhatia
Journal:  Int J Mol Sci       Date:  2021-12-27       Impact factor: 5.923

2.  A Novel Monoclonal Antibody 1D2 That Broadly Inhibits Clinically Important Aspergillus Species.

Authors:  Xihua Lian; Amy Scott-Thomas; John G Lewis; Madhav Bhatia; Stephen T Chambers
Journal:  J Fungi (Basel)       Date:  2022-09-14
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.